Merck KGaA (1MRK) Financial Statements
Merck KGaA Financial Overview
Merck KGaA's market cap is currently $65.78B. The company's EPS TTM is $5.45; its P/E ratio is 27.76; and it has a dividend yield of 1.45%. Merck KGaA is estimated to report earnings on November 12, 2026, and the estimated EPS forecast is $2.18. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 21.10B | $ 21.16B | $ 20.99B | $ 22.23B | $ 19.69B |
| Gross Profit | $ 11.89B | $ 11.95B | $ 11.67B | $ 12.84B | $ 11.60B |
| Operating Income | $ 4.07B | $ 4.37B | $ 4.04B | $ 5.00B | $ 4.28B |
| EBITDA | $ 5.45B | $ 5.55B | $ 5.52B | $ 6.28B | $ 5.93B |
| Net Income | $ 2.61B | $ 2.78B | $ 2.82B | $ 3.33B | $ 3.06B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.92B | $ 2.71B | $ 2.41B | $ 1.64B | $ 1.62B |
| Total Assets | $ 52.10B | $ 51.57B | $ 48.49B | $ 48.53B | $ 45.36B |
| Total Debt | $ 11.97B | $ 10.27B | $ 9.94B | $ 10.40B | $ 10.77B |
| Net Debt | $ 9.23B | $ 8.12B | $ 7.96B | $ 9.00B | $ 9.26B |
| Total Liabilities | $ 23.44B | $ 21.58B | $ 21.74B | $ 22.52B | $ 23.95B |
| Stockholders' Equity | $ 28.59B | $ 29.91B | $ 26.68B | $ 25.93B | $ 21.34B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.35B | $ 2.40B | $ 1.76B | $ 2.45B | $ 3.19B |
| Operating Cash Flow | $ 3.93B | $ 4.59B | $ 3.78B | $ 4.26B | $ 4.62B |
| Investing Cash Flow | $ -4.26B | $ -3.05B | $ -1.89B | $ -2.74B | $ -1.58B |
| Financing Cash Flow | $ 628.00M | $ -985.00M | $ -1.73B | $ -1.55B | $ -2.50B |
Currency in EUR
